Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Mallinckrodt
Chubb
UBS
Fish and Richardson
Federal Trade Commission
Cerilliant
Harvard Business School

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CAMPTOSAR

« Back to Dashboard

Clinical Trials for Camptosar

Trial ID Title Status Sponsor Phase Summary
NCT00004103 Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer Completed National Cancer Institute (NCI) Phase 2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.
NCT00004103 Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer Completed New York University School of Medicine Phase 2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.
NCT00004182 Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer Completed National Cancer Institute (NCI) Phase 2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent breast cancer.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Camptosar

Condition Name

Condition Name for Camptosar
Intervention Trials
Colorectal Cancer 13
Gastric Cancer 8
Metastatic Colorectal Cancer 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Camptosar
Intervention Trials
Colorectal Neoplasms 30
Adenocarcinoma 11
Glioma 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Camptosar

Trials by Country

Trials by Country for Camptosar
Location Trials
United States 294
United Kingdom 20
Canada 13
Japan 8
Italy 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Camptosar
Location Trials
California 22
Texas 22
Florida 19
Tennessee 17
North Carolina 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Camptosar

Clinical Trial Phase

Clinical Trial Phase for Camptosar
Clinical Trial Phase Trials
Phase 4 1
Phase 3 6
Phase 2 51
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Camptosar
Clinical Trial Phase Trials
Completed 45
Recruiting 24
Terminated 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Camptosar

Sponsor Name

Sponsor Name for Camptosar
Sponsor Trials
National Cancer Institute (NCI) 12
M.D. Anderson Cancer Center 9
Genentech, Inc. 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Camptosar
Sponsor Trials
Other 84
Industry 78
NIH 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Cipla
Chubb
Cantor Fitzgerald
Merck
Queensland Health
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.